Drug Interactions Theoretically, nonselective MAO inhibitors (phenelzine and tranylcypro- mne) taken with tolcapone may inhibit the major metabolic pathways of catecholamines, which may result in excessive adverse effects possibly due to levodopa accumulation. Corcomitant therapy is not recommended